STAT
NOVEMBER 4, 2024
This is Part 5 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. When patents for name brand medicines expire, the price of that medicine drops significantly as generic versions enter the market. Lower prices are good news for patients seeking more affordable medications, but the change can sometimes take a while.
Pharmacy Is Right For Me
NOVEMBER 4, 2024
Meet Lila, a passionate fourth-year Pharm.D. student at Auburn University Harrison College of Pharmacy. During her APPE rotation with the American Association of Colleges of Pharmacy , Lila opened up about her inspiring journey to find the perfect pharmacy school and how, with the guidance of mentors, she discovered her true “Pharmily.” How did you choose your pharmacy school/college or graduate program?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmacy mentor
NOVEMBER 3, 2024
Pharmacy Suppliers is a platform developed to simplify the process of connecting pharmacy owners with reliable and trusted suppliers throughout the UK. It offers a one-stop resource for pharmacy owners seeking for a variety of essential pharmacy products and services, such as Patient Medical Record (PMR) systems, EPOS Systems, Wholsalers, Pharmacy Buying Groups, Controlled Drug (CD) registers, Website Services, and much, much more.
Pharma Marketing Network
NOVEMBER 7, 2024
In today’s digital world, healthcare email marketing is more than just sending out newsletters. It’s a strategic tool that, when done right, can boost engagement, nurture relationships with healthcare professionals (HCPs), and increase brand awareness. But how can pharma companies truly maximize the potential of email marketing? Let’s dive in and explore some proven strategies.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Pharmacy Joe
NOVEMBER 3, 2024
In this episode, I’ll discuss whether a quinolone is really superior to a macrolide for legionella pneumonia. Episode 971: Is a Quinolone Really Superior to a Macrolide for Legionella Pneumonia? Subscribe on iTunes , Android , or Stitcher Traditionally it is thought that a bacteriocidal antibiotic is preferable to a bacteriostatic one, especially in severe infections such as legionella pneumonia.
STAT
NOVEMBER 5, 2024
Three independent pharmacies have filed separate lawsuits accusing GoodRx, which markets a prescription drug discount card, of conspiring with several pharmacy benefit managers to fix reimbursement fees, the latest skirmish over the opaque pharmaceutical supply chain in the U.S. At issue are the behind-the-scenes transactions involving generic drugs, which account for an estimated 90% of the prescriptions written in the U.S. and, consequently, represent a lucrative market.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Express Pharma
NOVEMBER 5, 2024
Venus Remedies has received Good Manufacturing Practices (GMP) approval with Pharmaceutical Inspection Co-operation Scheme (PIC/S) accreditation from the National Pharmaceutical Regulatory Agency (NPRA) of Malaysia for its pre-filled syringe (PFS) facility at its Baddi unit. This marks the first PIC/S GMP accreditation for the PFS facility and adds to the GMPs already secured by the company from more than 25 regulatory authorities, including the WHO and European Union.
Pharmaceutical Business Review
NOVEMBER 7, 2024
This partnership leverages SpectronRx’s advanced facilities for late-stage clinical and commercial supplies of the therapy. SpectronRx and Plus Therapeutics collaboration is set to accelerate nuclear medicine and improve supply chain redundancy for the production of Rhenium (186Re) Obisbemeda to meet upcoming commercial requirements and clinical trials.
STAT
NOVEMBER 6, 2024
Want to self-prescribe a prescription drug? No problem! Some of the largest pharmaceutical companies in the U.S. are piloting websites that essentially sell their drugs directly to consumers. This unprecedented move launches a new dystopic era: pharmaceutical companies as health care provider, no pesky physician middlemen needed. It’s what the pharmaceutical industry has always wanted: They have long viewed physicians as inconvenient barriers between the company and their customers.
The Pharmacist
NOVEMBER 6, 2024
Pharmacists should talk to patients about benefits other than cost savings to help tackle medicines wastage, a pharmacy lead told a Public Policy Projects (PPP) conference in London yesterday. In particular, talking about the impact of medicines on climate change could help to engage patients in medicines optimisation, he suggested. Speaking at the PPP Integrated […] The post Discussing climate impact helps engage patients in medicines optimisation appeared first on The Pharmacist.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Express Pharma
NOVEMBER 8, 2024
Quantiphi, an AI-first digital engineering company, and DDReg, a global leader in regulatory expertise, have announced a partnership aimed at addressing regulatory challenges faced by pharmaceutical, biotechnology, medical device, and cosmetics manufacturers. The collaboration seeks to expedite the process of bringing innovations to market by utilising artificial intelligence.
European Pharmaceutical Review
NOVEMBER 5, 2024
New data presented at Psych Congress 2024 has shown that the olanzapine long-acting injectable (LAI) TEV-‘749 / mdc-TJK demonstrated “significant improvement” in social functioning and quality of life in adults with schizophrenia. This was based on findings from the initial period (up to week 8) of the Phase III SOLARIS trial. According to Medincell, TEV-‘749 could be the first long-acting olanzapine medication with a favourable safety profile, because “other LAIs of olanzapine have been associa
STAT
NOVEMBER 6, 2024
LONDON — Sales of Novo Nordisk’s obesity drug Wegovy jumped in the third quarter, the company said Wednesday as it reported quarterly profits that were in line with analyst expectations. Novo’s third quarter performance will be seen as a win for the company, particularly after Eli Lilly — its rival in the booming obesity drug market — reported earnings last week that fell below forecasts.
Pharmafile
NOVEMBER 6, 2024
SolasCure, a biotechnology company which is dedicated to working towards filling the current market gap in debridement – the removal of neurotic tissue to encourage healing – and healing solutions for chronic wounds has announced a partnership with the US Army’s Institute of Surgical Research (USAISR). The partnership has aims to improve the current solutions […] The post SolasCure partners with US Army for better wound care technology appeared first on Pharmafile.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Express Pharma
NOVEMBER 7, 2024
On 7 November 2024, the U.S. Food and Drug Administration (FDA) announced a proposal to remove oral phenylephrine from over-the-counter (OTC) drugs marketed as nasal decongestants. The proposal follows an agency review that concluded oral phenylephrine is ineffective in providing temporary relief of nasal congestion. Until a final order is issued, however, companies may continue to sell OTC products containing oral phenylephrine for nasal decongestion.
Big Molecule Watch
NOVEMBER 7, 2024
On October 30, 2024, Shanghai Henlius Biotech and Organon announced that the FDA has accepted the Biologic License Application (BLA) for HLX14, a proposed biosimilar to PROLIA/XGEVA (denosumab). In 2022, Shanghai Henlius Biotech granted Organon exclusive commercialization rights for HLX14 in the U.S., EU, and Canada. The filing for HLX14 is supported by data from studies including analytical assessments and two clinical trials.
STAT
NOVEMBER 6, 2024
The executive in charge of AstraZeneca operations in China is under detention by Chinese authorities who are investigating employees there, the company said. The disclosure comes after AstraZeneca last week acknowledged that Leon Wang, an executive vice president who also oversees international operations for the drugmaker, was being investigated along with a “small number” of employees.
The Pharmacist
NOVEMBER 7, 2024
NICE has emphasised the importance of HRT in new guidance and clarified that cognitive behavioural therapy (CBT) should be an ‘add on’ treatment for menopausal symptoms. In its updated guidance, NICE has encouraged healthcare professionals to have ‘informed conversations’ with patients about the risks and benefits of HRT, and included a new ‘discussion aid’ to use […] The post New NICE guidance clarifies HRT as ‘first line treatment’ for menopause symptoms appeared first on The Pharmacist.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Express Pharma
NOVEMBER 6, 2024
Rubicon Research has received approval from the Securities and Exchange Board of India (SEBI) to proceed with an Initial Public Offering (IPO). The IPO will include a fresh issue of equity shares worth Rs 500 crore and an Offer For Sale (OFS) of shares valued at Rs 585 crore, sold by General Atlantic Singapore RR Pte, Rubicon’s promoter, as outlined in the Draft Red Herring Prospectus (DRHP) filed in July 2024.
European Pharmaceutical Review
NOVEMBER 4, 2024
The final text of Chapter <86> Bacterial Endotoxins Test Using Recombinant Reagents has been published for early option, according to US Pharmacopeia (USP). The chapter covers endotoxin testing using non-animal derived reagents and is set to become official in May 2025, the organisation announced. Further techniques for bacterial endotoxin testing (BET) using these alternative reagents, such as recombinant cascade (rCR) and recombinant Factor C (rFC) reagents, are included in Chapter
STAT
NOVEMBER 6, 2024
Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. Regardless of elections, we generally see the proverbial glass as half full. For those of you who worry the sky is falling, we will pass along something learned on Wall Street: “Sell sky.” After all, we have made it this far, so we are determined to hang on for another couple of days.
The Pharmacist
NOVEMBER 4, 2024
Any dispensations to provide financial relief for health bodies impacted by rising National Insurance contributions should include community pharmacy, Community Pharmacy England (CPE) has stressed. In a statement shared on Friday (1 November), Janet Morrison, CPE chief executive, said the negotiator was 'deeply concerned about the impact of the Autumn Budget on a pharmacy sector already […] The post Any National Insurance exemptions should include community pharmacy, says CPE appeared firs
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Drug Channels
NOVEMBER 4, 2024
Here on Drug Channels , we have long highlighted the boom in provider-administered biosimilars. In contrast to the pharmacy market, adoption of these biosimilars is growing, prices are dropping, and formulary barriers continue to fall. Novel transparency information reveals that this good news doesn’t always translate into savings. Below, we rely on a unique data set from Turquoise Health to examine how much four national commercial health plans—Aetna, Anthem, Cigna, and UnitedHealthcare—paid ho
PharmaTech
NOVEMBER 5, 2024
In the wake of the Food and Drug Administration's (FDA's) latest guidance on nitrosamine contamination, ensuring compliance and safeguarding pharmaceutical products is more critical than ever. This ebook provides a comprehensive roadmap for understanding nitrosamine risks and offers actionable strategies to mitigate potential impurities. Through expert insights from Adare Pharma Solutions, you’ll learn how to remain compliant, identify risks, and implement cutting-edge strategies for nitrosamine
STAT
NOVEMBER 8, 2024
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We expect to continue the never-ending quest to manicure the Pharmalot grounds, promenade with the official mascots, and catch up on napping. We also hope to hold another listening party, where the rotation will likely include this , this , this , this and this.
European Pharmaceutical Review
NOVEMBER 6, 2024
Dupixent (dupilumab) has been approved by the European Medicines Agency (EMA) as the first treatment for young children with eosinophilic esophagitis in the EU. This authorisation is based on Phase III data which found that 68 percent of children aged one to 11 years given Dupixent (dupilumab) achieved histological disease remission at 16 weeks. This result was maintained for up to one year.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Express Pharma
NOVEMBER 4, 2024
Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk’s diabetes drug, liraglutide, to its platform in 2025. “We have already confirmed a core supplier for this addition and over the next few months expect to finish completing test and batch validation, as well as confirming certificates of analysis,” the company said.
The Pharmacist
NOVEMBER 8, 2024
Adding in just five minutes of vigorous exercise to a daily routine can help lower blood pressure, a large study has concluded. Analysis of data from more than 14,700 people across five countries found that short periods of exercise that increases heart rate, such as cycling and climbing stairs, had a measurable benefit. Using fitness […] The post Just five minutes of vigorous exercise a day can lower blood pressure appeared first on The Pharmacist.
STAT
NOVEMBER 4, 2024
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so predictable routine of online meetings, phone calls, and deadlines has returned. But you knew this would happen, yes? The world, such as it is, continues to spin. So to cope, we are brewing a cup of stimulation in the Pharmalot cafeteria.
Drug Patent Watch
NOVEMBER 7, 2024
The rising cost of prescription drugs has become a significant public health concern, with millions of Americans struggling to afford their medications. One crucial factor in mitigating this issue is the increased use of generic drugs. Generic drugs have been instrumental in reducing healthcare costs, and their impact cannot be overstated.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Expert insights. Personalized for you.
328 
Let's personalize your content